Xenetic Biosciences, Inc. (XBIO): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2018-12-31
$130.1K2012-12-31: $130.1K2013-12-31: $78.6K2014-12-31: $57.7K2015-12-31: $1.7K2016-12-31: $16.8K2017-12-31: $9.3K2018-12-31: $0$0
2012-12-31 Capital Expenditures (USD) 2018-12-31
Period endedCapital ExpendituresChange YoYSource filing
2018-12-31$0-100.0%2019-03-29, From 2018-01-01
2017-12-31$9.3K-44.8%2019-03-29, From 2017-01-01
2016-12-31$16.8K+909.8%2018-03-30, From 2016-01-01
2015-12-31$1.7K-97.1%2017-03-31, From 2015-01-01
2014-12-31$57.7K-26.7%2016-03-30, From 2014-01-01
2013-12-31$78.6K-39.6%2015-07-20, From 2013-01-01
2012-12-31$130.1Kn/a2015-07-20, From 2012-01-01